July 2019 |
|
Grassley Statement on FDA’s Capability Assessments for European Union Member States
|
|
Grassley Statement on Withdrawal of HHS Rebate Rule
|
|
Grassley on Rx Relief for American Taxpayers & Consumers
|
|
Grassley, Wyden Applaud USTR Investigation of French Digital Services Tax Proposal
|
|
Grassley-backed Private Debt Collection Program Bolsters IRS Collection Resources
|
|
Grassley, Durbin Vow to Keep Pushing for List Prices on DTC Drug Advertisements
|
|
Grassley Receives Response from DoD on Foreign Threats to Taxpayer-Funded Research
|
|
Grassley-Led Bipartisan IRS Reform Bill Becomes Law
|
|
ICYMI: The media needs to stop getting the Republican tax cuts wrong
|
|
Grassley, Wyden Press for Answers on Financial Relationships Between Opioid Manufacturers and Tax-Exempt Organizations
|
June 2019 |
|
Grassley Statement on the Resumption of U.S.-Chinese Trade Talks
|
|
Grassley Presses HHS, FDA on Safety and Quality Control of Foreign Drug Manufacturing Facilities
|
|
Grassley: New Hospital Co-location Rules Positive Step for Rural Communities, Needs More Clarity to Ensure Successful Implementation
|
|
Grassley On Tax Treaties and Protocols
|
|
Grassley: Trump’s Executive Order on Health Care Transparency Will Benefit Every American
|